Showing results (211-220 of 238) with videos related to
Sort By:
Pageof 24
Blood Cancer Journal|July 26, 2012
Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain productionF L Khanim, B A M E Merrick, H V Giles, et al.The New England Journal of Medicine|January 25, 1990
Absence of HIV infection in blood donors with indeterminate western blot tests for antibody to HIV-1J B Jackson, K L MacDonald, J Cadwell, et al.European Journal of Immunology|December 18, 2001
Requirement for CD28 co-stimulation is lower in SHP-1-deficient T cellsJ G Sathish, K G Johnson, F G LeRoy, et al.Journal of Acquired Immune Deficiency Syndromes|April 1, 1994
A phase I/II trial of intravenous L-2-oxothiazolidine-4-carboxylic acid (procysteine) in asymptomatic HIV-infected subjectsR C Kalayjian, G Skowron, R T Emgushov, et al.The Journal of Infectious Diseases|May 24, 2001
Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377)S H Eshleman, P Krogstad, J B Jackson, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
Safety, tolerability, and antiretroviral effects of ritonavir-nelfinavir combination therapy administered for 48 weeksC P Raines, C Flexner, E Sun, et al.The Journal of Infectious Diseases|December 20, 2000
Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcersJ M Jacobson, J S Greenspan, J Spritzler, et al.AIDS (London, England)|October 16, 2001
Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)S H Eshleman, M Mracna, L A Guay, et al.Physical Chemistry Chemical Physics : PCCP|September 4, 2014
Dielectric, calorimetric and mesophase properties of 1''-(2',4-difluorobiphenyl-4'-yloxy)-9''-(4-cyanobiphenyl-4'-yloxy) nonane: an odd liquid crystal dimer with a monotropic mesophase having the characteristics of a twist-bend nematic phaseN Sebastián, D O López, B Robles-Hernández, et al.Annual Review of Immunology|March 13, 2001
The immunological synapseS K Bromley, W R Burack, K G Johnson, et al.Pageof 24